Skip to main content
. 2019 Aug;40(8):1317–1322. doi: 10.3174/ajnr.A6142

Table 1:

Clinical and demographic patient characteristics by symptom-to-MRI time and the presence of FVHa

Characteristics Group 1 (n = 191)
Group 2 (n = 164)
Group 3 (n = 104)
FVH (−) (n = 74) FVH (+) (n = 117) P Value FVH (−) (n = 63) FVH (+) (n = 101) P Value FVH (−) (n = 44) FVH (+) (n = 60) P Value
Women 27 (36.5) 37 (31.6) .53 20 (31.7) 27 (26.7) .60 10 (22.7) 20 (33.3) .28
Age (yr) 60.7 ± 14.3 63.9 ± 12.5 .11 66 (46–73) 65.5 (54–74) .88 55.1 ± 13.7 63.6 ± 11.0 .001b
Symptom-to-admission time (days) 3 (2–4) 2 (1–4) .05 5 (4–7) 4 (3–7) .21 16.5 (12–31) 19.5 (12–30.75) .79
Risk factors
    Hypertension 58 (78.4) 82 (70.1) .24 35 (55.6) 70 (69.3) .09 31 (70.5) 45 (75) .66
    Diabetes mellitus 29 (39.2) 28 (23.9) .03b 16 (25.4) 36 (35.6) .23 12 (27.3) 13 (21.7) .64
    Hypercholesterolemia 24 (32.4) 43 (36.8) .64 24 (38.1) 30 (29.7) .31 8 (18.2) 8 (13.3) .59
    Smoker 24 (32.4) 52 (44.4) .13 25 (39.7) 48 (47.5) .34 19 (43.2) 26 (43.3) 1.00
    Coronary heart disease 5 (6.8) 6 (5.1) .88 1 (1.6) 6 (5.9) .35 6 (13.6) 5 (8.3) .59
    Atrial fibrillation 4 (5.4) 8 (6.8) .93 2 (3.2) 1 (1.0) .88 1 (2.3) 2 (3.3) 1.00
    Previous stroke 18 (24.3) 29 (24.8) 1.00 9 (14.3) 25 (24.8) .12 9 (20.5) 19 (31.7) .27
NIHSS score at admission 4 (2–7) 6 (3–10) .02b 4 (2–9) 5 (2–9) .32 5 (2–10) 4.5 (2–9) .56
Hospitalization (days) 10.5 (8–13) 13 (10–16) .001b 12 (9–15) 13 (9–15) .95 13.5 (8–15) 12.5 (9.25–16) .94
Outcome at discharge
    mRS 2 (1–3) 3 (2–4) <.001b 2 (1–3) 3 (2–4) .10 2.5 (1–4) 3 (1.25–4) .54
    mRS ≥ 2 54 (73.0) 100 (85.5) .04b 43 (68.3) 85 (84.2) .02b 31 (70.5) 45 (75.0) .66
    mRS ≥ 3 31 (41.9) 70 (59.8) .02b 29 (46.0) 52 (51.5) .52 22 (50.0) 34 (56.7) .55

Note:—(−) indicates negative; (+), positive.

a

Data are No. (%), mean ± SD, and median (interquartile range).

b

P < .05.